Race Against Blood Cancer

Stem cell and bone marrow transplants are now regularly used as a curative treatment for patients with blood cancer, such as lymphoma, myeloma and leukaemia. Race Against Blood Cancer works to increase the number of people from minority groups – whether defined by race, ethnicity or gender – which are vastly underrepresented on the donor registry as stem cell donors.